Variant report

Variant	nsv878699
Chromosome Location	chr4:10744931-10874933
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:15)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:10838222..10840730-chr4:10845508..10847395,2	MCF-7	breast:
2	chr4:10792379..10794491-chr4:10813231..10815298,2	K562	blood:
3	chr4:10756345..10760061-chr4:10764457..10766284,3	MCF-7	breast:
4	chr4:10755307..10757742-chr4:10758971..10761170,2	K562	blood:
5	chr4:10756345..10760061-chr4:10764457..10766284,3	MCF-7	breast:
6	chr4:10755307..10757742-chr4:10758971..10761170,2	K562	blood:
7	chr4:10872629..10875072-chr4:10883830..10886796,2	MCF-7	breast:
8	chr4:10859482..10861042-chr4:10861383..10863426,2	MCF-7	breast:
9	chr4:10831389..10833247-chr4:10834600..10836541,2	MCF-7	breast:
10	chr4:10838222..10840730-chr4:10845508..10847395,2	MCF-7	breast:
11	chr4:10859482..10861042-chr4:10861383..10863426,2	MCF-7	breast:
12	chr4:10792379..10794491-chr4:10813231..10815298,2	K562	blood:
13	chr17:57915709..57917415-chr4:10837885..10839837,2	MCF-7	breast:
14	chr4:10120346..10122071-chr4:10783813..10786571,2	MCF-7	breast:
15	chr4:10831389..10833247-chr4:10834600..10836541,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DRD5-6	chr4:10750796-10751216	XLOC_003453
2	lnc-DRD5-6	chr4:10750796-10751216	XLOC_003453
3	lnc-DRD5-7	chr4:10760725-10760877	XLOC_003454
4	lnc-DRD5-6	chr4:10750796-10751199	NONHSAT095512
5	lnc-DRD5-7	chr4:10810351-10810544	XLOC_003454
6	lnc-DRD5-6	chr4:10750796-10751209	XLOC_003453

No data

Variant related genes	Relation type
MIER3	miRNA target sites
CDK1	miRNA target sites
LDLRAP1	miRNA target sites

Extended variants
information (count: 2924 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:2924 , 50 per page) page: 1 2 3 4 5 6 7 ... 59

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12640839	chr4:10744931-10744932	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs188255368	chr4:10744958-10744959	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs534514465	chr4:10744992-10744993	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs566438622	chr4:10745087-10745088	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs77882144	chr4:10745112-10745113	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs116744716	chr4:10745156-10745157	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs567011992	chr4:10745183-10745184	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs141585967	chr4:10745225-10745226	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs538316005	chr4:10745230-10745231	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs557481267	chr4:10745251-10745252	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs373502219	chr4:10745263-10745264	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs546442776	chr4:10745265-10745266	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs557889071	chr4:10745314-10745315	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs147514466	chr4:10745317-10745318	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs77532243	chr4:10745324-10745325	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs150814523	chr4:10745365-10745366	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs77822017	chr4:10745404-10745405	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs12644098	chr4:10745417-10745418	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs192938426	chr4:10745436-10745437	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs577898331	chr4:10745536-10745537	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs544915722	chr4:10745543-10745544	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs138147929	chr4:10745574-10745575	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs562669964	chr4:10745613-10745614	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs533100723	chr4:10745648-10745649	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs551684316	chr4:10745671-10745672	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs566635281	chr4:10745729-10745730	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs560393588	chr4:10745776-10745777	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs182474982	chr4:10745786-10745787	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs34803480	chr4:10745841-10745842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs572199525	chr4:10745843-10745844	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs186750308	chr4:10745855-10745856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs567022640	chr4:10745878-10745879	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs541518692	chr4:10745952-10745953	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs191265811	chr4:10746009-10746010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs573325335	chr4:10746082-10746083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs149587104	chr4:10746140-10746141	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs78758180	chr4:10746150-10746151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs144306139	chr4:10746172-10746173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs371101590	chr4:10746235-10746236	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs567274305	chr4:10746263-10746264	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs573574971	chr4:10746317-10746318	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs375231062	chr4:10746377-10746378	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs559859657	chr4:10746455-10746456	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs540635549	chr4:10746514-10746515	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs555758942	chr4:10746618-10746619	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs116568578	chr4:10746650-10746651	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs560513195	chr4:10746724-10746725	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs140487423	chr4:10746776-10746777	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs78419272	chr4:10746834-10746835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs184841715	chr4:10746835-10746836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	22241247	CNVD
Autosomal-dominant microtia	18179897	CNVD
Glioma	17123091	CNVD
Colorectal cancer	20459617	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:256 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:10726000-10747800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr4:10742200-10745800	Enhancers	Primary B cells from peripheral blood	blood
3	chr4:10743000-10746800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr4:10743000-10747800	Weak transcription	NH-A	brain
5	chr4:10743400-10745800	Flanking Active TSS	GM12878-XiMat	blood
6	chr4:10743600-10745200	Enhancers	Fetal Thymus	thymus
7	chr4:10743600-10747600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr4:10743600-10747800	Weak transcription	Muscle Satellite Cultured Cells	--
9	chr4:10743600-10752600	Weak transcription	Osteobl	bone
10	chr4:10743800-10745000	Enhancers	Thymus	Thymus
11	chr4:10744800-10745000	Enhancers	Primary B cells from cord blood	blood
12	chr4:10745000-10745200	Flanking Active TSS	Primary B cells from cord blood	blood
13	chr4:10745200-10746200	Enhancers	Primary B cells from cord blood	blood
14	chr4:10745800-10746800	Weak transcription	GM12878-XiMat	blood
15	chr4:10745800-10748600	Weak transcription	Primary B cells from peripheral blood	blood
16	chr4:10746200-10749000	Weak transcription	Primary B cells from cord blood	blood
17	chr4:10746800-10748600	Enhancers	GM12878-XiMat	blood
18	chr4:10746800-10749600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr4:10746800-10749600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr4:10747400-10748600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr4:10747400-10748800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr4:10747600-10749200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr4:10747800-10748000	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr4:10747800-10748600	Enhancers	HSMMtube	muscle
25	chr4:10747800-10749000	Enhancers	Muscle Satellite Cultured Cells	--
26	chr4:10747800-10749000	Enhancers	Fetal Muscle Leg	muscle
27	chr4:10747800-10749000	Enhancers	NH-A	brain
28	chr4:10747800-10749200	Enhancers	HSMM	muscle
29	chr4:10747800-10749600	Enhancers	Cortex derived primary cultured neurospheres	brain
30	chr4:10748000-10748400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr4:10748000-10748400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
32	chr4:10748000-10749200	Enhancers	Colon Smooth Muscle	Colon
33	chr4:10748200-10749200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr4:10748400-10749000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr4:10748400-10750600	Enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr4:10748600-10748800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr4:10748600-10748800	Flanking Active TSS	GM12878-XiMat	blood
38	chr4:10748600-10749000	Flanking Active TSS	HSMMtube	muscle
39	chr4:10748600-10749200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr4:10748600-10749200	Enhancers	Primary B cells from peripheral blood	blood
41	chr4:10748600-10749200	Enhancers	Ovary	ovary
42	chr4:10748800-10749200	Active TSS	GM12878-XiMat	blood
43	chr4:10748800-10749800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr4:10749000-10749200	Enhancers	Primary B cells from cord blood	blood
45	chr4:10749000-10749200	Enhancers	HSMMtube	muscle
46	chr4:10749000-10752000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr4:10749000-10755200	Weak transcription	Fetal Muscle Leg	muscle
48	chr4:10749200-10750000	Enhancers	GM12878-XiMat	blood
49	chr4:10749200-10752200	Weak transcription	Colon Smooth Muscle	Colon
50	chr4:10749200-10755000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links